Gencor reports that a new study that has been submitted for publication found that its proprietary fenugreek extract, Testofen, increased strength, endurance, and lean body mass is healthy, active males.
Photo © iStockphoto.com
A new unpublished study shows that Gencor’s (Irvine, CA) proprietary fenugreek extract (Testofen) increases strength, aerobic endurance, and lean body mass in healthy, active men. The double-blind, randomized, dose response, eight-week clinical trial was conducted at RDC Global with 138 healthy, non-smoking male subjects, and examined changes in lean body mass, fat mass, upper and lower body muscular strength, and endurance. Results showed that the extract acted in a dose-response manner, with 600 mg per day of Testofen in conjunction with an effective exercise routine demonstrating superior positive effects when compared to placebo, or 300 mg of Testofen per day.
“These significant and positive results show that Testofen may be an effective ergogenic aid for those wanting to rapidly improve their exercise performance and body composition above and beyond exercise training only,” said Chase Shryoc, vice president of sales and business development for Gencor, in a press release. “We are thrilled about the results of this study and look forward to incorporating Testofen into its next sports nutrition product.”
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.